Skip to main content
(
Log in
)
Side panel
MENU
Dashboard
Home
About Us
About Us
FAQs
The Frank Foundation
Board Members
Publications
Quality Assurance
Guests
Learners
Mentors
Universities
Courses
All Courses
Medicine Courses
Public Health Courses
Community Health Courses
Professional Development Courses
Nursing Courses
Health Sciences
Sciences
Programs
Addiction Training for Health Professionals
Public Health U - MPH
Primary Education STEPS
Humanitarian U
Connect
Contact Us
Volunteer
Careers
Join Our Network
sign up for our newsletter
Donate
Blog
Curso de cesación y tratamiento del consumo de tabaco y nicotina para Profesionales de la Salud
Resumen de Módulo 1
414.3KB PDF document
Click
MÓDULO 1 Introducción y rol del profesional.pdf
link to view the file.
◄ Presentación Dr. Eduardo Bianco
Jump to...
Jump to...
Announcements
Prueba previa
Presentación Dr. Eduardo Bianco
Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update
International Statistical Classification of Diseases and Related Health Problems (ICD)
Smoking Cessation: A Report of the Surgeon General: Full Report: 2020
WHO clinical treatment guideline for tobacco cessation in adults
Quitting Smoking Among Adults — United States, 2000–2015
Guidelines for implementation of Article 14
Training package: strengthening health systems for treating tobacco dependence in primary care. Geneva: WHO; 2013
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
Guidelines for implementation of Article 14
Foro breve: Actividad 1
Quiz Módulo 1
Presentación Dra. Nelci Becerra
MÓDULO 2. Identificación del usuario
WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030
Stages and processes of self-change of smoking: Toward an integrative model of change.
WHO clinical treatment guideline for tobacco cessation in adults
Stages and processes of self-change of smoking: Toward an integrative model of change.
Quitting Smoking Among Adults — United States, 2000–2015
The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
FACTS ABOUT SECOND-HAND SMOKE WHO
Beliefs About the Health Effects of "Thirdhand" Smoke and Home Smoking Bans
Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer
Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking
Recruiting and engaging smokers in treatment in a primary care setting: developing a chronic care model implemented through a modified electronic health record
CASO CLÍNICO1
Quiz Módulo 2
Presentación Dra Luisa Guell 5As
Presentación Dra. Laura Jimeno 5Rs
MÓDULO 3 Intervención breve
Behavioural interventions for smoking cessation: an overview and network meta‐analysis
Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings
Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance
WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: WHO; 2024.
WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: World Health Organization; 2024.
Adapting health promotion interventions to meet the needs of ethnic minority groups: mixed-methods evidence synthesis
MPOWER WHO
Ask Advise Connect: A New Approach to Smoking Treatment Delivery in Healthcare Settings
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline
CASO CLÍNICO
Presentación Dra. Luz Helena Alba
Video: "Intervención en paciente motivado"
Video Video: "Intervención incorrecta sobre paciente no motivado"
Video: "Intervención correcta sobre paciente no motivado"
Video en Ingles: "Intervención integral y recomendada en paciente no motivado"
Módulo 4 Intervenciones motivacionales y conductuales
Effectiveness of counseling methods in reducing smoking habits for patients with cardiovascular disease: A literature review
WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: WHO; 2024.
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
Smoking Cessation: A Report of the Surgeon General: Full Report: 2020
Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline
Motivational interviewing for smoking cessation
Caso Clínico
Quiz Módulo 4
Presentación Terapia de Reemplazo Nicotínica
Presentacion Dra. Lidia Amarales Bupropion
Presentación Dr. Carlos Jiménez C Ruiz
Presentación Dr. Gustavo Zabert: Vareniclina
Presentación Dr. Eduardo Bianco Combinación de fármacos
MÓDULO 5. Introducción al Tratamiento farmacológico
Treatment for Tobacco Dependence: Effect on Brain Nicotinic Acetylcholine Receptor Density
Gotti C, Clementi FNeuronal nicotinic receptors: from structure to pathology
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation
Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Combination Pharmacotherapy for Stopping Smoking
Toll free quitlines
Cytisine for smoking cessation
Caso clínico
Quiz Módulo 5
Presentación Dr. Gustavo Zabert
Presentación Dra. Tania Palacios
MÓDULO 6 Seguimiento y recaída
Chronic Disease Management for Tobacco Dependence A Randomized, Controlled Trial
Outcome criteria in smoking cessation trials: proposal for a common standard
Relapse prevention for addictive behaviors
The First 7 Days of a Quit Attempt Predicts Relapse
Caso Clinico
Presentación Dra. Nelci Becerra Intervenciones Digitales
MÓDULO 7 Quitlines e intervenciones digitales
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
WHO clinical treatment guideline for tobacco cessation in adults
Mobile phone text messaging and app‐based interventions for smoking cessation
Smoking Cessation: A Report of the Surgeon General
Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline
Telephone counselling for smoking cessation
Presentación Dr. Eduardo Bianco. Cesación y reducción de daño
Módulo 8. Cesación y reducción de daño
CASO CLÍNICO
Caso integrador final: Cesación en paciente con EPOC, alta dependencia y dudas sobre vapeo
Evaluación del Curso
Autoevaluación
Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update ►
Curso de cesación y tratamiento del consumo de tabaco y nicotina
General
¿Cómo crear una cuenta e inscribirse en el curso?
Curso de cesación y tratamiento del consumo de tabaco y nicotina para Profesionales de la Salud Homepage
Bienvenida
Cuestionario sobre Interferencia de la Industria Tabacalera
Introducción curso de Curso de cesación y tratamiento del consumo de tabaco y nicotina para Profesionales de la Salud
MÓDULO 1. Introducción al problema del tabaquismo y su tratamiento. Rol de Profesionales de la Salud.
Actividad interactiva: Módulo 1
MÓDULO 2. Identificación del usuario
Actividad Interactiva Módulo 2.
MÓDULO 3. Intervención breve
Actividad Interactiva Módulo 3
MÓDULO 4. Intervenciones motivacionales y conductuales
Actividad Interactiva Módulo 4
MÓDULO 5. Introducción al Tratamiento farmacológico
Actividad Interactiva Módulo 5
MÓDULO 6. Seguimiento y recaída
Actividad Interactiva Módulo 6
Módulo 7 . Quitlines e intervenciones digitales
Módulo 8. Cesación y reducción de daño
Actividad Interactiva Módulo 8
Módulo 9 :Caso estudio de Integración práctica
Examen Final
Curso, autoevaluación y certificado
Home
